Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma.
2018
e21610Background: Talimogene Laherparepvec (T-Vec), a modified Herpes Simplex Type I (HSV I) virus, is the first oncolytic virus to be FDA approved for the treatment of cancer. T-Vec has two propos...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI